Table 2. Scientific findings and technical advancement for the characterisation of women with intermediate G6PD activity.
| Reference | Year
published |
Main findings |
|---|---|---|
| Beutler et al. | 1955 | Development of the GSH test for sensitivity to primaquine |
| Beutler et al. | 1955 | Development of the Heinz Bodies test for sensitivity to
primaquine |
| Alving, et al. | 1958 | Primaquine associated haemoglobin reduction observed
in individuals with intermediate activity |
| Childs, et al. | 1958 | |
| Gross, et al. | 1958 | |
| Tarlov, et al. | 1962 | |
| Brewer, et al. | 1960 * | Development of the methaemoglobin reduction test (MRT)
for sensitivity to primaquine |
| Stamatoyannopoulos, et al. | 1967 | Description of the enzymatic phenotypes in small samples
of known G6PD heterozygous females |
| Panizon, et al. | 1970 | |
| Rinaldi, et al. | 1976 | |
| Beutler et al. | 1977 | Gold standard spectrophotometric assay |
| Van Noorden, et al. | 1985 | Description of new or improved cytochemical techniques
for detection of G6PD in erythrocytes |
| Vives-Corrons, et al. | 1986 | |
| Vogels, et al. | 1986 | |
| Fanello, et al. | 2008 | Dapsone associated haemolysis in G6PD heterozygous
females (no phenotype) |
| Premji, et al. | 2009 | |
| Tiono, et al. | 2009 | |
| Pamba, et al. | 2012 | |
| Shah, et al. | 2012 | Development of the cytofluorometric reading of MRT |
| Chu, et al. | 2017 | Primaquine and tafenoquine associated haemolysis in
G6PD heterozygous females with intermediate activity |
| Rueangweerayut, et al. | 2017 |
* For ease of visualization, this article is listed out of chronological order